Day: May 13, 2020

CHICAGO, May 13, 2020 (GLOBE NEWSWIRE) — Tribune Publishing (NASDAQ:TPCO) today announced it will report its financial results for the first quarter on Friday, May 22, 2020.The Company will host a conference call to discuss its business and financial results at 8:30 a.m. Eastern time (7:30 a.m. Central time). The conference call may be accessed via Tribune Publishing’s Investor Relations website at investor.tribpub.com or by dialing 844.494.0195 (508.637.5599 for international callers) and entering conference ID 1045919. A replay of the webcast will also be available for one year on the Tribune Publishing website. To access the replay via telephone, dial 855.859.2056 (404.537.3406 for international callers), conference ID 1045919.About Tribune PublishingTribune Publishing (NASDAQ: TPCO) is a media company rooted in award-winning...

BIRMINGHAM, Mich., May 13, 2020 (GLOBE NEWSWIRE) — Conifer Holdings, Inc. (Nasdaq: CNFR) (“Conifer” or the “Company”) today announced results for the first quarter ended March 31, 2020.First Quarter 2020 Financial Highlights (compared to the prior year period)Gross written premium increased 3.6% to $25.1 million due to growth in commercial specialty linesCommercial Lines combined ratio was 112.8% (accident year combined ratio was 94.9%)Personal Lines combined ratio was 96.9% (accident year combined ratio was 92.9%)The Company’s overall combined ratio was 111.6% (accident year combined ratio was 94.7%)Net loss of $4.7 million, or $0.49 per share based on 9.6 million average shares outstanding; largely due to a decline in the fair value of equity securities resulting from disruption in financial markets related to the COVID-19 pandemicManagement...

All three patients in Cohort 3 now confirmed respondersAll three complete responders in the study remain clinically and metabolically stable after longer-term follow-upUltragenyx to host ASGCT recap investor conference call Friday, May 15 at 8:30 a.m. Eastern TimeNOVATO, Calif., May 13, 2020 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare diseases, today announced positive longer-term safety and efficacy data from the first three cohorts of the ongoing Phase 1/2 study of DTX301, an investigational adeno-associated virus (AAV) gene therapy for the treatment of ornithine transcarbamylase (OTC) deficiency. Six of nine patients in the study have responded to the gene therapy (three female, three male),...

WILMINGTON, Del., May 13, 2020 (GLOBE NEWSWIRE) — Acorn Energy, Inc. (OTCQB: ACFN), a provider of remote monitoring and control systems and IoT services for generators, pipelines, compressors and other industrial equipment through its OmniMetrix subsidiary, today announced results for its first quarter (Q1’20) ended March 31, 2020. Acorn will host an investor call tomorrow, May 14th at 11:00 a.m. ET to discuss its results and outlook (details below).Jan Loeb, Acorn’s CEO, commented, “Our Q1’20 topline and bottomline performance were relatively stable versus Q1’19, despite business development headwinds. Monitoring revenue rose 17% in Q1’20 but was offset by a 21% decrease in hardware sales, reflecting energy industry challenges and some business disruption from the Coronavirus pandemic. Q1’20 gross margin improved to 69%,...

Frisco, TX, May 13, 2020 (GLOBE NEWSWIRE) — Comstock Resources, Inc. (NYSE: CRK) (“Comstock” or the “Company”) announced today that it has commenced an underwritten public offering of 40 million shares of its common stock (the “Common Stock Offering”).  Comstock also intends to grant the underwriters a 30-day option to purchase up to 6 million additional shares of common stock.Comstock intends to use the net proceeds from the offering to redeem the Company’s Series A Redeemable Convertible Preferred Stock for $210 million plus accrued and unpaid dividends and to reduce amounts outstanding under its bank credit facility. Citigroup is acting as the sole book-running manager and representative of the underwriters for the offering.The offering of these securities is being made pursuant to an effective shelf registration statement. The...

NEW YORK, May 13, 2020 (GLOBE NEWSWIRE) — New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) is scheduled to report financial results for the three months ended March 31, 2020 after the close of market on May 21, 2020. New York Mortgage Trust’s executive management will host a conference call and audio webcast at 9:00 a.m., Eastern Time, on Friday, May 22, 2020. The conference call dial-in number is 877-312-8806.A live audio webcast of the conference call can be accessed via the Internet, on a listen-only basis, at the Investor Relations section of the Company’s website at www.nymtrust.com. Please allow extra time, prior to the call, to visit the site and download the necessary software to listen to the Internet broadcast.A replay of the conference call will be available by calling 855-859-2056. The conference...

SAN FRANCISCO, May 13, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), today reported its financial results for the first quarter ended March 31, 2020 and provided an update on the company’s operations.The company is working with its committed partners to minimize disruption from the COVID-19 pandemic on its clinical trials and other drug development programs. BridgeBio salutes the brave physicians, nurses, first responders and medical staff who are working across the globe to care for patients with COVID-19.BridgeBio’s fully enrolled trials and preclinical programs are moving ahead with minimal delays, and the company is on track to file its second New Drug Application (NDA) later this year, along with the anticipated filing of multiple investigational new drug applications (INDs). Despite the challenges presented...

L’essai eNRGy de phase 1/2 du MCLA-128 (zenocutuzumab reste) sur la bonne voieMise à jour du programme MCLA-117 qui sera présenté lors du prochain congrès médicalAnand Mehra, M.D. doit succéder à Russell Greig, Ph.D. au poste de président et Paolo Pucci a été désigné pour être nommé au conseil d’administration de MerusUTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 13 mai 2020 (GLOBE NEWSWIRE) — Merus NV (Nasdaq : MRUS) (« Merus », la « Société », « nous » ou « notre »), une société d’oncologie au stade clinique qui développe des anticorps multispécifiques de pleine longueur innovants (Biclonics® et Triclonics™), a annoncé aujourd’hui ses résultats financiers pour le premier trimestre clos le 31 mars 2020 et a fait le point sur ses activités.« Nous avons progressé dans nos programmes cliniques malgré les effets...

MCLA-128, Zenocutuzumab, eNRGy-Studie der Phase I/II bleibt im ZeitplanUpdate zum MCLA-117-Programm wird auf bevorstehender medizinischer Tagung präsentiertAnand Mehra, M.D. tritt Nachfolge von Russell Greig, Ph.D. als Vorsitzender an und Paolo Pucci ist für die Berufung in den Vorstand von Merus nominiertUTRECHT, Niederlande, und Cambridge, Mass., May 13, 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) („Merus“, die „Gesellschaft“, „wir“ oder „unser“), ein Unternehmen aus dem Bereich der klinischen Onkologie, das innovative multispezifische volllange Antikörper (Biclonics® und TriclonicsTM) entwickelt, gab heute die Finanzergebnisse für das erste Quartal zum 31. März 2020 bekannt und legte ein Update zur Geschäftsentwicklung vor.„Wir haben trotz der Auswirkungen der aktuellen COVID-19-Pandemie Fortschritte bei unseren klinischen...

SANTA MONICA, Calif., May 13, 2020 (GLOBE NEWSWIRE) — SUPER LEAGUE GAMING, INC. (NASDAQ: SLGG) (“Super League Gaming” or the “Company”), a global leader in competitive video gaming and esports entertainment for everyday players around the world, today announced it has entered into securities purchase agreements with institutional investors for the purchase and sale of 1,825,000 shares of common stock, par value $0.001 per share at an offering price of $3.50 per share, pursuant to a registered direct offering, priced at-the-market under Nasdaq rules. The gross proceeds of the offering will be approximately $6,387,500 before deducting fees and other estimated offering expenses. The closing of the registered direct offering is expected to take place on or about May 15, 2020, subject to the satisfaction of customary closing conditions.A.G.P./Alliance...